Association of the receptor for advanced glycation end products gene polymorphisms with diabetic retinopathy in type 2 diabetes: A meta-analysis

Ophthalmologica

Volumn 227, Issue 4, 2012, Pages 223-232

  Yuan, Dongqing ^a   Yuan, Donglan ^a   Liu, Qinghuai ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Diabetic retinopathy; Meta analysis; Polymorphisms; Receptor for advanced glycation end products; Type 2 diabetes

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; GLYCINE; SERINE;

ALLELE; ARTICLE; DIABETIC RETINOPATHY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PUBLISHING; SENSITIVITY ANALYSIS;

ALLELES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; GENOTYPE; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC; RISK FACTORS;

EID: 84862825076     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000335628     Document Type: Article

References (35)

1. Marshall SM, Flyvbjerg A: Prevention and early detection of vascular complications of diabetes. BMJ 2006; 333: 475-480.
2. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J; China National Diabetes and Metabolic Disorders Study Group: Prevalence of diabetes among men and women in China. N Engl J Med 2010; 362: 1090-1101.
3. Yamagishi S, Ueda S, Matsui T, Nakamura K, Okuda S: Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy. Curr Pharm Des 2008; 14: 962-968.
4. Stitt AW: AGEs and diabetic retinopathy. Invest Ophthalmol Vis Sci 2010; 51: 4867-4874.
5. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, Tanji N, Lu Y, Lalla E, Fu C, Hofmann MA, Kislinger T, Ingram M, Lu A, Tanaka H, Hori O, Ogawa S, Stern DM, Schmidt AM: Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 2000; 405: 354-360.
6. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820.
7. Liu Y, Liang C, Liu X, Liao B, Pan X, Ren Y, Fan M, Li M, He Z, Wu J, Wu Z: AGEs increased migration and inflammatory responses of adventitial fibroblasts via RAGE, MAPK and NF-kappaB pathways. Atherosclerosis 2010; 208: 34-42.
8. Alexiou P, Chatzopoulou M, Pegklidou K, Demopoulos VJ: RAGE: a multi-ligand receptor unveiling novel insights in health and disease. Curr Med Chem 2010; 17: 2232-2252.
9. Kashiwagi A, Araki S: Relation between polymorphisms G1704T and G82S of RAGE gene and diabetic retinopathy in Japanese type 2 diabetic patients. Intern Med 2005; 44: 397-398.
10. Hudson BI, Stickland MH, Futers TS, Grant PJ: Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 2001; 50: 1505-1511.
11. Globocnik Petrovic M, Steblovnik K, Peterlin B, Petrovic D: The -429 T/C and -374 T/A gene polymorphisms of the receptor of advanced glycation end products gene are not risk factors for diabetic retinopathy in Caucasians with type 2 diabetes. Klin Monbl Augenheilkd 2003; 220: 873-876.
12. Zhang HM, Chen LL, Wang L, Liao YF, Wu ZH, Ye F, Xu S, Yi LL: Association of 1704G/T and G82S polymorphisms in the receptor for advanced glycation end products gene with diabetic retinopathy in Chinese population. J Endocrinol Invest 2009; 32: 258-262.
13. Uthra S, Raman R, Mukesh BN, Rajkumar SA, Kumari P, Lakshmipathy P, Gnanamoorthy P, Sharma T, McCarty CA, Kumaramanickavel G: Diabetic retinopathy: validation study of ALR2, RAGE, iNOS and TNFB gene variants in a south Indian cohort. Ophthalmic Genet 2010; 31: 244-251.
14. World Health Organization: Diabetes mellitus. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1985; 727: 1-113.
15. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26(suppl 1):S5-S20.
16. American Diabetes Association: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197.
17. JiXiong X, BiLin X, MingGong Y, ShuQin L: -429T/C and -374T/A polymorphisms of RAGE gene promoter are not associated with diabetic retinopathy in Chinese patients with type 2 diabetes. Diabetes Care 2003; 26: 2696-2697.
18. dos Santos KG, Canani LH, Gross JL, Tschiedel B, Pires Souto KE, Roisenberg I: The -374A allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic heart disease in African-Brazilians with type 2 diabetes. Mol Genet Metab 2005; 85: 149-156.
19. Ramprasad S, Radha V, Mathias RA, Majumder PP, Rao MR, Rema M: Rage gene promoter polymorphisms and diabetic retinopathy in a clinic-based population from South India. Eye (Lond) 2007; 21: 395-401.
20. Balasubbu S, Sundaresan P, Rajendran A, Ramasamy K, Govindarajan G, Perumalsamy N, Hejtmancik JF: Association analysis of nine candidate gene polymorphisms in Indian patients with type 2 diabetic retinopathy. BMC Med Genet 2010; 11: 158.
21. Lindholm E, Bakhtadze E, Cilio C, Agardh E, Groop L, Agardh CD: Association between LTA, TNF and AGER polymorphisms and late diabetic complications. PLoS One 2008; 3:e2546.
22. Kumaramanickavel G, Ramprasad VL, Sripriya S, Upadyay NK, Paul PG, Sharma T: Association of Gly82Ser polymorphism in the RAGE gene with diabetic retinopathy in type II diabetic Asian Indian patients. J Diabetes Complications 2002; 16: 391-394.
23. Yoshioka K, Yoshida T, Takakura Y, Umekawa T, Kogure A, Toda H, Yoshikawa T: Relation between polymorphisms G1704T and G82S of rage gene and diabetic retinopathy in Japanese type 2 diabetic patients. Intern Med 2005; 44: 417-421.
24. Warboys CM, Toh HB, Fraser PA: Role of NADPH oxidase in retinal microvascular permeability increase by RAGE activation. Invest Ophthalmol Vis Sci 2009; 50: 1319-1328.
25. Zong H, Ward M, Madden A, Yong PH, Limb GA, Curtis TM, Stitt AW: Hyperglycaemiainduced pro-inflammatory responses by retinal Müller glia are regulated by the receptor for advanced glycation end-products (RAGE). Diabetologia 2010; 53: 2656-2666.
26. El-Asrar AM, Missotten L, Geboes K: Expression of high-mobility groups box-1/receptor for advanced glycation end products/ osteopontin/early growth response-1 pathway in proliferative vitreoretinal epiretinal membranes. Mol Vis 2011; 17: 508-518.
27. Sugaya K, Fukagawa T, Matsumoto K, Mita K, Takahashi E, Ando A, Inoko H, Ikemura T: Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3. Genomics 1994; 23: 408-419.
28. Kirbis J, Milutinovic A, Steblovnik K, Teran N, Terzic R, Zorc M: The -429 T/C and -374 T/A gene polymorphisms of the receptor of advanced glycation end products gene (RAGE) are not risk factors for coronary artery disease in Slovene population with type 2 diabetes. Coll Antropol 2004; 28: 611-616.
29. Lu W, Feng B: The -374A allele of the RAGE gene as a potential protective factor for vascular complications in type 2 diabetes: a meta-analysis. Tohoku J Exp Med 2010; 220: 291-297.
30. Kankova K, Benes P, Kuchrickova S: Functional analysis of the common haplotype in the receptor for advanced glycation endproducts gene previously identified as a susceptibility factor for diabetic nephropathy. Exp Clin Endocrinol Diabetes 2010; 118: 93-95.
31. Hudson BI, Stickland MH, Grant PJ: Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups. Diabetes 1998; 47: 1155-1157.
32. Munafo MR, Flint J: Meta-analysis of genetic association studies. Trends Genet 2004; 20: 439-444.
33. Poon PY, Szeto CC, Chow KM, Kwan BC, Li PK: Relation between polymorphisms of receptor for advanced glycation end products (RAGE) and cardiovascular diseases in Chinese patients with diabetic nephropathy. Clin Nephrol 2010; 73: 44-50.
34. Kankova K, Beranek M, Hajek D, Vlkova E: Polymorphisms 1704G/T, 2184A/G, and 2245G/A in the rage gene are not associated with diabetic retinopathy in NIDDM: pilot study. Retina 2002; 22: 119-121.
35. Kankova K, Stejskalova A, Hertlova M, Znojil V: Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus. Nephrol Dial Transplant 2005; 20: 1093-1102.